Related references
Note: Only part of the references are listed.The contextual brain: implications for fear conditioning, extinction and psychopathology
Stephen Maren et al.
NATURE REVIEWS NEUROSCIENCE (2013)
Potential molecular mechanisms for decreased synaptic glutamate release in dysbindin-1 mutant mice
Shalini Saggu et al.
SCHIZOPHRENIA RESEARCH (2013)
Targeting cognitive deficits in schizophrenia: a review of the development of a new class of medicines from the perspective of community mental health researchers
Oleg V. Tcheremissine et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
Frequency dependency of NMDA receptor-dependent synaptic plasticity in the hippocampal CA1 region of freely behaving mice
Arne Buschler et al.
HIPPOCAMPUS (2012)
Dysbindin-1 modulates prefrontal cortical activity and schizophrenia-like behaviors via dopamine/D2 pathways
F. Papaleo et al.
MOLECULAR PSYCHIATRY (2012)
Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction
M. Ayalew et al.
MOLECULAR PSYCHIATRY (2012)
Structural and functional neuroimaging phenotypes in dysbindin mutant mice
Evan Lutkenhoff et al.
NEUROIMAGE (2012)
Reduced Dysbindin Expression Mediates N-Methyl-D-Aspartate Receptor Hypofunction and Impaired Working Memory Performance
Katherine H. Karlsgodt et al.
BIOLOGICAL PSYCHIATRY (2011)
Lack of Change in Markers of Presynaptic Terminal Abundance Alongside Subtle Reductions in Markers of Presynaptic Terminal Plasticity in Prefrontal Cortex of Schizophrenia Patients
Samantha J. Fung et al.
BIOLOGICAL PSYCHIATRY (2011)
Cognitive Control Deficits in Schizophrenia: Mechanisms and Meaning
Tyler A. Lesh et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Synaptic Dysbindin-1 Reductions in Schizophrenia Occur in an Isoform-Specific Manner Indicating Their Subsynaptic Location
Konrad Talbot et al.
PLOS ONE (2011)
The treatment of cognitive impairment in schizophrenia
Donald C. Goff et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2011)
Dysbindin-1 mutant mice implicate reduced fast-phasic inhibition as a final common disease mechanism in schizophrenia
Gregory C. Carlson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Analysis of HapMap tag-SNPs in dysbindin (DTNBP1) reveals evidence of consistent association with schizophrenia
J. Voisey et al.
EUROPEAN PSYCHIATRY (2010)
Dysfunction of dopamine release in the prefrontal cortex of dysbindin deficient sandy mice: An in vivo microdialysis study
Taku Nagai et al.
NEUROSCIENCE LETTERS (2010)
The Role of Genetics in the Etiology of Schizophrenia
Pablo V. Gejman et al.
PSYCHIATRIC CLINICS OF NORTH AMERICA (2010)
Behavioral characterization of dysbindin-1 deficient sandy mice
Sanjeev K. Bhardwaj et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Mixture Model Clustering of Phenotype Features Reveals Evidence for Association of DTNBP1 to a Specific Subtype of Schizophrenia
Jaana Wessman et al.
BIOLOGICAL PSYCHIATRY (2009)
Cognitive Effects of Second-Generation Antipsychotics Current Insights into Neurochemical Mechanisms
Fabio Fumagalli et al.
CNS DRUGS (2009)
Neuroplasticity as a target for the pharmacotherapy of anxiety disorders, mood disorders, and schizophrenia
John H. Krystal et al.
DRUG DISCOVERY TODAY (2009)
Neurobehavioral abnormalities in the dysbindin-1 mutant, sandy, on a C57BL/6J genetic background
M. M. Cox et al.
GENES BRAIN AND BEHAVIOR (2009)
Dysbindin-1 in dorsolateral prefrontal cortex of schizophrenia cases is reduced in an isoform-specific manner unrelated to dysbindin-1 mRNA expression
Junxia Tang et al.
HUMAN MOLECULAR GENETICS (2009)
LTP in hippocampal area CA1 is induced by burst stimulation over a broad frequency range centered around delta
Lawrence M. Grover et al.
LEARNING & MEMORY (2009)
The dystrobrevin-binding protein 1 gene: features and networks
A. Y. Guo et al.
MOLECULAR PSYCHIATRY (2009)
Dysbindin Modulates Prefrontal Cortical Glutamatergic Circuits and Working Memory Function in Mice
James David Jentsch et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Dysbindin regulates hippocampal LTP by controlling NMDA receptor surface expression
Tina Tze-Tsang Tang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Role of dysbindin in dopamine receptor trafficking and cortical GABA function
Yuanyuan Ji et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Dysconnection in Schizophrenia: From Abnormal Synaptic Plasticity to Failures of Self-monitoring
Klaas E. Stephan et al.
SCHIZOPHRENIA BULLETIN (2009)
Behavioral abnormalities and dopamine reductions in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia
Satoko Hattori et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
DTNBP1, a schizophrenia susceptibility gene, affects kinetics of transmitter release
Xiao-Wei Chen et al.
JOURNAL OF CELL BIOLOGY (2008)
Reduced DTNBP1 (dysbindin-1) mRNA in the hippocampal formation of schizophrenia patients
Cynthia Shannon Weickert et al.
SCHIZOPHRENIA RESEARCH (2008)
Impaired long-term memory retention and working memory in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia
Keizo Takao et al.
Molecular Brain (2008)
Neuroplasticity of neocortical circuits in schizophrenia
David A. Lewis et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Synaptic plasticity: Multiple forms, functions, and mechanisms
Ami Citri et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Evidence that the BLOC-1 protein dysbindin modulates dopamine D2 receptor internalization and signaling but not D1 internalization
Yukihiko Iizuka et al.
JOURNAL OF NEUROSCIENCE (2007)
High dopamine turnover in the brains of Sandy mice
Tomotaka Murotani et al.
NEUROSCIENCE LETTERS (2007)
Hippocampal abnormalities and memory deficits: New evidence of a strong pathophysiological link in schizophrenia
Patrice Boyer et al.
BRAIN RESEARCH REVIEWS (2007)
Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin
Konrad Talbot et al.
HUMAN MOLECULAR GENETICS (2006)
Synaptic plasticity and dysconnection in schizophrenia
Klaas E. Stephan et al.
BIOLOGICAL PSYCHIATRY (2006)
D-alanine added to antipsychotics for the treatment of schizophrenia
GE Tsai et al.
BIOLOGICAL PSYCHIATRY (2006)
Neural circuits and mechanisms involved in Pavlovian fear conditioning: A critical review
JJ Kim et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2006)
Differences in the magnitude of long-term potentiation produced by theta burst and high frequency stimulation protocols matched in stimulus number
RV Hernandez et al.
BRAIN RESEARCH PROTOCOLS (2005)
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
PJ Harrison et al.
MOLECULAR PSYCHIATRY (2005)
Brain-derived neurotrophic factor plays a critical role in contextual fear conditioning
IYC Liu et al.
JOURNAL OF NEUROSCIENCE (2004)
Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain
CS Weickert et al.
ARCHIVES OF GENERAL PSYCHIATRY (2004)
Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia
T Numakawa et al.
HUMAN MOLECULAR GENETICS (2004)
The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications
PJ Harrison
PSYCHOPHARMACOLOGY (2004)
Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia
K Talbot et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1)
W Li et al.
NATURE GENETICS (2003)
Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia
RE Straub et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
Placebo-controlled trial of D-cycloserine added to conventional neuroleptics, olanzapine, or risperidone in schizophrenia
U Heresco-Levy et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Formation of temporal memory requires NMDA receptors within CA1 pyramidal neurons
PT Huerta et al.
NEURON (2000)
Neurocognitive deficits and functional outcome in schizophrenia: Are we measuring the right stuff?
MF Green et al.
SCHIZOPHRENIA BULLETIN (2000)
Share Paper
